Breaking News Instant updates and real-time market news.

STM

STMicroelectronics

$17.30

-0.02 (-0.12%)

, IFNNY

Infineon

$22.70

0.05 (0.22%)

15:20
08/08/17
08/08
15:20
08/08/17
15:20

Infineon beats out STMicroelectronics for Model 3 contract, Inside EVs says

While it previously appeared STMicroelectronics (STM) had won a deal to supply chips for Tesla's (TSLA) mass-market Model 3, it now turns out that Infineon (IFNNY) has secured the deal, according to Inside EVs. The CEO of Infineon, which makes battery and motor chips for the majority of the top-selling EVs globally and currently has its chips used in Tesla's Model S, said, "We do not comment on the individual models, but we will also will be present in Model 3," according to the report. Reference Link

STM

STMicroelectronics

$17.30

-0.02 (-0.12%)

IFNNY

Infineon

$22.70

0.05 (0.22%)

TSLA

Tesla

$355.17

-1.74 (-0.49%)

  • 08

    Aug

  • 29

    Aug

  • 02

    Oct

STM STMicroelectronics
$17.30

-0.02 (-0.12%)

07/11/17
07/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KeyCorp (KEY) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Klock saying he sees valuation expansion as the market further appreciates the company's leading return on assets and stable earnings. 2. Exxon Mobil (XOM) and Imperial Oil (IMO) were upgraded to Overweight from Equal Weight at Barclays. 3. Westar Energy (WR) was upgraded to Outperform from In Line at Evercore ISI and to Overweight from Neutral at JPMorgan. 4. STMicroelectronics (STM) upgraded to Overweight from Neutral at JPMorgan with analyst Sandeep Deshpande citing the stock's underperformance over the past three months. 5. J.M. Smucker (SJM) upgraded to Long-Term Buy on valuation at Hilliard Lyons with analyst Jeffrey Thomison citing the recent decline in shares and maintained a $140 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/17
JPMS
07/11/17
UPGRADE
JPMS
Overweight
STMicroelectronics upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Sandeep Deshpande upgraded STMicroelectronics (STM) to Overweight citing the stock's underperformance over the past three months. The analyst believes the market is underestimating the company's second half of 2017 potential. The 3D sensing win at Apple (AAPL) and silicon carbide win at Tesla (TSLA) are likely to drive positive earnings estimate revisions in 2018, Deshpande tells investors in a research note. He has a EUR 16.30 price target for the shares.
06/28/17
CHLM
06/28/17
NO CHANGE
Target $20
CHLM
Buy
STMicroelectronics pullback a buying opportunity, says Craig-Hallum
Craig-Hallum analyst Anthony Stoss believes STMicroelectronics' fundamentals remain intact and he views the recent pullback in the stock as a "great buying opportunity" ahead of the company's earnings report, as he expects a "beat and raise" coming in late July. Stoss keeps a Buy rating and $20 price target on STMicroelectronics shares.
06/27/17
STFL
06/27/17
UPGRADE
STFL
Buy
STMicroelectronics upgraded to Buy from Hold at Stifel
IFNNY Infineon
$22.70

0.05 (0.22%)

05/15/17
GSCO
05/15/17
UPGRADE
GSCO
Buy
Infineon upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Alexander Duval upgraded Infineon to Buy and raised his price target for the shares to EUR 22 from EUR 19.
04/26/17
ROTH
04/26/17
NO CHANGE
Target $27
ROTH
Buy
Roth Capital says Cree post-earnings weakness 'overdone'
Roth Capital analyst Craig Irwin argues that the post-earnings weakness in Cree (CREE) is "overdone" given that its earnings miss -- while difficult -- was smaller than peers. The analyst concedes, however, that the turnaround in Cree's Lighting Products segment is "taking longer than anyone would like," leading him to take a materially more conservative view of the unit. Irwin also updates his models to now include Cree's Wolfspeed. The proposed sale of Wolfspeed to Infineon (IFNNY) collapsed earlier this year, and while it remains attractive and "could see a sale to a third party," the analyst argues that a trade sale of the business "looks highly unlikely at this point." He lowered his price target on Cree shares to $27 from $33 but keeps a Buy rating on the stock.
03/14/17
NEED
03/14/17
DOWNGRADE
NEED
Hold
Mobileye downgraded to Hold from Buy at Needham
Needham analyst Rajvindra Gill downgraded Mobileye (MBLY) to Hold from Buy after Intel (INTC) announced its intention to acquire all of the former's outstanding ordinary shares for $63.54 per share. The analyst believes the deal clearly validates the ADAS and fully autonomous vehicle market, and views it as a positive read-through into the entire ADAS and automotive supply chain, namely ON Semiconductor (ON), Micron (MU), Cypress Semiconductor (CY), NXP Semiconductors (NXPI), NVIDIA (NVDA), Tower Semiconductor (TSEM), and Infineon (IFNNY).
02/09/17
ROTH
02/09/17
NO CHANGE
Target $34
ROTH
Buy
Cree should be bought on volatility, says Roth Capital
Roth Capital analyst Craig Irwin expects shares of Cree (CREE) to be near-term weak after the company announced CFIUS impediments for closing the sale of Wolfspeed to Infineon (IFNNY). The analyst believes that originally there were additional bidders for the Wolfspeed assets, albeit with lower final offers, allowing resumption of the sale process with an alternate. Irwin would be a buyer on volatility driven by short-term uncertainty. He reiterates a Buy rating and $34 price target on the shares.
TSLA Tesla
$355.17

-1.74 (-0.49%)

08/08/17
08/08/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Buy from Hold at Argus with analyst William Selesky saying he expects Tesla to reach breakeven two quarters earlier than he'd previously forecast and sees the company achieving full-year profitability in fiscal 2019. 2. L3 Technologies (LLL) upgraded to Buy from Hold at Drexel Hamilton analyst Pete Skibitski saying he is "cautiously" optimistic that there will be a positive resolution in fiscal 2018 budget negotiations, which will benefit the entire space, and notes L3's international outlook has improved as the year has progressed. 3. Foot Locker (FL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Jay Sole saying he believes share weakness related to investor concerns surrounding share loss to Amazon (AMZN) and brands' own websites has created an "excellent" buying opportunity. 4. UPS (UPS) upgraded to Buy from Neutral at Citi with analyst Christian Wetherbee saying he sees a "clear path" toward double-digit earnings growth returning in 2018. 5. Cognizant (CTSH) upgraded to Buy from Hold at Berenberg with analyst Georgios Kertsos saying the market now considers U.S. immigration policy changes as unlikely, which leaves upside for investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/17
ARGS
08/08/17
UPGRADE
Target $444
ARGS
Buy
Tesla upgraded to Buy on strong Model 3 orders at Argus
As previously reported, Argus analyst William Selesky upgraded Tesla to Buy from Hold and set a $444 price target on the shares. He noted that Tesla has been getting 1,800 Model 3 orders per day without any advertising or marketing so far. While he notes the ramp-up of the mass market vehicle will lead to increased labor and overhead costs he expect those to diminish over the course of next year. Selesky now expects Tesla to reach breakeven two quarters earlier than he'd previously forecast and sees the company achieving full-year profitability in FY19.
08/08/17
ARGS
08/08/17
UPGRADE
Target $444
ARGS
Buy
Tesla upgraded to Buy from Hold at Argus
08/03/17
BOFA
08/03/17
NO CHANGE
Target $155
BOFA
Underperform
Tesla price target lowered to $155 from $165 at BofA/Merrill
BofA/Merrill analyst John Murphy said Tesla's Q2 results were a bit noisy, but generally above expectations. He said Model 3 ramp volume still remains unclear and expects it to take some time before it reaches any material scale, which could lead to production costs outweighing potential benefits of higher volume operating leverage for an extended time. The analyst expects Tesla will need to raise capital by year-end and believes investor patience will wear thin as further capital raises are net met with improving earnings, cash flow, or returns. Murphy lowered Tesla's price target to $155 from $165 on slightly lower forward estimates and maintains an Underperform rating.

TODAY'S FREE FLY STORIES

09:10
09/24/18
09/24
09:10
09/24/18
09:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

CMCSA

Comcast

$37.91

0.1 (0.26%)

, DIS

Disney

$110.72

-0.9 (-0.81%)

09:09
09/24/18
09/24
09:09
09/24/18
09:09
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Disney (DIS), up…

CMCSA

Comcast

$37.91

0.1 (0.26%)

DIS

Disney

$110.72

-0.9 (-0.81%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

AMRN

Amarin

$3.00

0.06 (2.04%)

EPZM

Epizyme

$10.30

-0.1 (-0.96%)

P

Pandora

$9.08

-0.31 (-3.30%)

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

GOLD

Randgold

$63.94

-0.64 (-0.99%)

ABX

Barrick Gold

$10.48

-0.135 (-1.27%)

XON

Intrexon

$14.50

-0.035 (-0.24%)

NTNX

Nutanix

$46.55

-1.43 (-2.98%)

BILI

Bilibili

$12.47

-0.93 (-6.94%)

ANAB

AnaptysBio

$92.83

0.61 (0.66%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 27

    Sep

  • 01

    Oct

  • 02

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 10

    Dec

IMPV

Imperva

$45.65

-0.6 (-1.30%)

, FIVN

Five9

$43.21

-1.32 (-2.96%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Conference/Events
Microsoft to hold a conferenc e »

Microsoft Ignite will be…

IMPV

Imperva

$45.65

-0.6 (-1.30%)

FIVN

Five9

$43.21

-1.32 (-2.96%)

CDAY

Ceridian

$42.07

-0.855 (-1.99%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 28

    Nov

  • 03

    Mar

MNKD

MannKind

$1.71

0.02 (1.18%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Hot Stocks
MannKind completes cohort 1, opens enrollment of cohort 2 for Afrezza study »

MannKind announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

CZR

Caesars

$10.78

-0.175 (-1.60%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Hot Stocks
Caesars names Monica Digilio as Chief Human Resources Officer »

Caesars Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$147.81

-5.105 (-3.34%)

09:06
09/24/18
09/24
09:06
09/24/18
09:06
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$6.46

-0.05 (-0.77%)

, CMCSA

Comcast

$37.91

0.1 (0.26%)

09:05
09/24/18
09/24
09:05
09/24/18
09:05
Periodicals
Tile names GoPro vet CJ Prober CEO, adds Comcast as investor, TechCrunch says »

Tile is appointing CJ…

GPRO

GoPro

$6.46

-0.05 (-0.77%)

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNBX

Cannabics Pharmaceuticals

$0.00

(0.00%)

09:04
09/24/18
09/24
09:04
09/24/18
09:04
Syndicate
Cannabics Pharmaceuticals raises $7.5M in a registered direct offering »

Cannabics Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$107.62

-0.32 (-0.30%)

09:03
09/24/18
09/24
09:03
09/24/18
09:03
Recommendations
Quest Diagnostics analyst commentary  »

Quest Diagnostics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALPMY

Astellas Pharma

$0.00

(0.00%)

, PFE

Pfizer

$44.06

0.3 (0.69%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Hot Stocks
Astellas Pharma receives positive CHMP opinion for Xtandi »

Astellas Pharma announced…

ALPMY

Astellas Pharma

$0.00

(0.00%)

PFE

Pfizer

$44.06

0.3 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

ALT

Altimmune

$26.03

0.53 (2.08%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Syndicate
Altimmune raises $4.9M in a registered direct offering »

Altimmune announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALT

Altimmune

$26.03

0.53 (2.08%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Syndicate
Altimmune announces $4.9M registered direct offering of common stock »

Altimmune announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$69.05

0.25 (0.36%)

09:02
09/24/18
09/24
09:02
09/24/18
09:02
Recommendations
Abbott analyst commentary  »

Abbott Mitraclip data a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
Breaking Hot Stocks news story on Sirius XM »

Sirius XM doesn't…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

PDLI

PDL BioPharma

$2.42

-0.02 (-0.82%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
PDL BioPharma announces new $100M share repurchase program »

PDL BioPharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBEV

New Age Beverages

$6.15

-1.7 (-21.66%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Syndicate
New Age Beverages to offer up to $50M in shares via 'At the Market' offering »

New Age Beverages…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

09:01
09/24/18
09/24
09:01
09/24/18
09:01
Hot Stocks
Sirius XM says company, Pandora to pay royalties approaching $2B in 2019 »

Sirius XM (SIRI) says…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

RDC

Rowan Companies

$18.02

0.54 (3.09%)

08:59
09/24/18
09/24
08:59
09/24/18
08:59
Upgrade
Rowan Companies rating change  »

Rowan Companies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SEAS

SeaWorld

$30.10

-0.5 (-1.63%)

08:58
09/24/18
09/24
08:58
09/24/18
08:58
Recommendations
SeaWorld analyst commentary  »

SeaWorld price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTRX

Lantronix

$4.14

-0.12 (-2.82%)

08:58
09/24/18
09/24
08:58
09/24/18
08:58
Recommendations
Lantronix analyst commentary  »

Lantronix shares can see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AAPL

Apple

$217.65

-2.35 (-1.07%)

08:57
09/24/18
09/24
08:57
09/24/18
08:57
Recommendations
Apple analyst commentary  »

Rosenblatt says Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TEUM

Pareteum

$2.80

-0.03 (-1.06%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Initiation
Pareteum initiated  »

Pareteum initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTV

Fortive

$86.97

-0.45 (-0.51%)

, AAPL

Apple

$217.65

-2.35 (-1.07%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Options
Notable open interest changes for September 24th »

Friday's total…

FTV

Fortive

$86.97

-0.45 (-0.51%)

AAPL

Apple

$217.65

-2.35 (-1.07%)

AMD

AMD

$31.01

-0.17 (-0.55%)

MU

Micron

$44.70

-1.36 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

, ANDV

Andeavor

$154.80

2.19 (1.44%)

08:55
09/24/18
09/24
08:55
09/24/18
08:55
Conference/Events
Andeavor to host special shareholder meeting »

Special Shareholder…

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

ANDV

Andeavor

$154.80

2.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

08:54
09/24/18
09/24
08:54
09/24/18
08:54
Hot Stocks
Breaking Hot Stocks news story on Sirius XM, Pandora, Spotify »

Sirius XM sees taking…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

SPOT

Spotify

$175.06

2.38 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.